“GE’s partner in their new crowd funding venture is with an equity crowdfunding platform called OurCrowd. Scott Kurnitt, an OurCrowd investor, believes GE likes the OurCrowd model because, ‘We don’t have to hand over our money to a fund and hope they invest it properly. We can decide what to invest in deal by deal.’ Kurnitt also likes that OurCrowd provides post investment support to its portfolio companies like making industry introductions, marketing assistance and strong mentorship.”
Meet California-born Israeli Jonathan Medved, whose startup brings together Zionism and crowdfunding.
There is no doubt about it, Israel is at the forefront of cutting-edge technologies in hundreds of various fields, pushing the boundaries in art and culture, biotech, medicine, the environment, science and technology. From drip irrigation to gadgets like the Disk-on-Key, from solar windows to the PillCam, almost any device you pick up has it’s origins in Israeli tech. The Startup Nation’s remarkable ingenuity constantly produces breakthroughs in products and processes that affect the way people around the world live their every day lives.
With that in mind (no pun intended), it’s interesting to take a look at what innovations the top brains in Israel are working on in the neuroscience field. Bioassociate, a consulting firm for investors and businesses operating in the life science arena, put together a collection of Israel’s most prominent and promising brain tech companies, all of whom they claim exhibit a particular fondness for the word “brain”. Take a look at our summary below!
Five Israeli Brain Techs to Watch
Jerusalem-based Brainsway is a developer and marketer of Deep TMS systems, a novel, noninvasive medical device for treatment of a wide range of neurological and psychopathological disorders. Brainsway’s initial focus is the treatment of major depression but the company is working on expanding their therapeutic targets to include addiction, schizophrenia, obesity, eating disorders, Parkinson’s disease, Alzheimer’s disease, autism and post-traumatic stress disorder. Last month the company raised NIS 24 million and signed a $1M agreement with a Japanese distributor.
Established in 2000, BrainsGate is a medical device company committed to developing innovative therapies for patients suffering from Central Nervous System (CNS) diseases. BrainsGate’s platform technology involves electrical stimulation of the Spheno-Palatine Ganglion (SPG), a nervous center known to increase cerebral blood flow.
BrainStorm Cell Therapeutics is a biotechnology company developing innovative adult stem cell therapies for neurodegenerative diseases, such as Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig’s Disease), Parkinson’s Disease, and Multiple Sclerosis. The company’s approach uses the patient’s own bone marrow to generate NeuroTrophic Factor (NTF)-secreting cells for transplantation at or near the site of damage, to maximize both safety and clinical efficacy. BrainStorm has received a lot of attention from international media for the highly positive preliminary results of it’s NurOwn technology, currently in Phase IIa dose-escalating clinical trials in Israel.
Founded in 2006, ElMindA is a neurodiagnostic company with a potential to take the ambiguous guesswork out of the way brain disorders are diagnosed. ElMindA has developed the BNA™ technology platform, which for the first time allows high resolution visualization and evaluation of the complex neuro-physiological interconnections of the human brain at work, capturing information on the composition, connectivity, synchronization and operation of brain networks. In July of this year, ElMindA received The Most Promising Company Award at the Personalized Medicine World Conference (PMWC) International 2013.
Neuronix, founded in 2008, is working on introducing new methods for modifying the course of treatment for Neuro-degenerative Diseases and in particular Alzheimer Disease (AD). Neuronix’s neuroAD technology is currently undergoing advanced clinical trials in major medical centers across the globe. This patent-pending technology uses stimulation of affected brain regions concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s disease. The stimulation induces LTP (Long-Term Potentiation), which is associated with learning and memory processes, and results in a measurable cognitive improvement after just a few weeks of treatment.
From Startup Nation to Brain Nation
This past October, Israel held it’s first Brain Technology Conference where scientists, academic leaders, Nobel prize-winning neuroscientists, engineers, public officials, entrepreneurs and industry executives from around the world gathered in Tel Aviv to discuss the Israeli Neurotechnology Industry, global brain initiatives, and investing in brain technology. Israeli President Shimon Peres, who spoke at the conference, was the visionary behind this international meeting of the minds. Peres aims to promote leading-edge research of the brain and turn Israel into a brain technology hub.
There are a lot exciting projects underway in the biomedical sphere in Israel which translate into a lot of interesting investment opportunities that help advance the health and quality of life for people around the world.
So, if you consider yourself a brainiac — start thinking about investing in the future of our brains (literally)!
OurCrowd’s Portland-based portfolio company Lucid Energy, a provider of renewable energy systems, was featured on Bloomberg Television’s “Bloomberg West.” Planet Forward Host Frank Sesno interviewed Lucid Energy CEO Gregg Semler and discussed the company’s development of hydroelectric power that doesn’t hurt the environment.
Lucid Energy’s patented LucidPipe™ Power System enables industrial, municipal and agricultural facilities to generate clean, reliable, low-cost electricity from the water grid.
View the video below or play it on Bloomberg TV here.
Jerusalem, Israel November 4, 2013: OurCrowd, Israel’s leading equity crowdfunding platform for accredited investors, announced today that it has closed a strategic co-investment partnership with GE Ventures, the corporate venture capital unit of GE.
Read more here.
“OurCrowd has created a unique platform for dynamic early stage origination and funding,” said GE Ventures CEO Sue Siegel in a statement. “They offer a quality investment environment, and the partnership will give GE increased access to early innovation.”
As part of our new relationship, GE Ventures will have the right to co-invest with OurCrowd in early stage companies from the energy, healthcare, software, and advanced manufacturing sectors.
This means a lot for our investments and portfolio companies but it also underscores the fact that the investment playing field is being levelled — OurCrowd investors get access to the same deals multi-billion dollar corporations are seeing, at the same terms.
OurCrowd CEO Jon Medved said, “We are thrilled to partner with GE Ventures on co-investments via our equity crowdfunding platform. GE brings unequaled expertise and experience in a broad range of technologies and businesses that will add real value to our portfolio companies and to our investor community. To partner with a company of GE’s size and stature will allow OurCrowd to help break new ground in innovation finance.”
Read the full press release here.
Join the OurCrowd team and fellow investors at various events during the annual JFNA General Assembly conference taking place in Israel, November 10 – 12, 2013.
GA Late Night with OurCrowd
Scotch, wine and comedy by the walls, featuring comedy by Avi Lieberman
Sunday, November 10th, 10:00 PM, at the Jerusalem Press Club
Get more info and reserve your space online
Born in Israel and raised in Texas, Avi Liberman is a comedian who has performed stand-up on CBS’ “Late Late Show” with Craig Ferguson on Comedy Central’s “Premium Blend” and “Make Me Laugh” as well as NBC’s “Friday Night!” Since 2001, Avi has arranged charitable comedy tours throughout Israel, including “Comedy for Koby,” the proceeds of which benefit the Koby Mandell Foundation.
Exclusive Investor Breakfast
Exclusive breakfast for accredited investors only — meet the founders and CEO’s of Israel’s most exciting startups in an intimate setting featuring a select group of startups OurCrowd is investing in!
Wednesday, November 13th, 8:00-10:00AM at the King David Hotel.
Please sign up here to save your seat at the breakfast, and we will be in touch to confirm your registration.
Jon Medved session on crowdfunding at the GA
Hear Jon & fellow panelists on “Crowdfunding: Harnessing the power of the people”
Monday, November 11th, 11:00 AM – 12:15 PM, at the General Assembly
Events at OurCrowd’s booth at the GA
Stop by OurCrowd’s booth at the conference to meet Start-up Nation CEO’s, brainstorm with game theory fundraising experts, talk start-up investing with the OurCrowd team and much more throughout the conference
Sunday – Monday at the General Assembly.
Questions? Email Danna Mann for more information.